RSS
24 Mar 2020

The Lancet Haematology Publishes Results From Oncopeptides’ Multicenter, International Phase 1/2 Study (O-12-M1)

Author: admintech | Filed under: Press Release

STOCKHOLM, March 24, 2020 /PRNewswire/ — Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the publication of results from its O-12-M1 study, melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM), a multicenter, international, open-label, phase 1/2 study in…

This entry was posted on Tuesday, March 24th, 2020 at 7:16 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»